N-Propyl Bromide

N-Propyl Bromide

SCHEMBL7075476

CCCBr.C[Si]1(C)CC[Si](C)(C)N1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9695124 0.84 TSHR (0.35)
SCHEMBL524412 0.78
SCHEMBL4527817 0.75
N-Propyl Bromide SCHEMBL15864866 0.67
N-Propyl Bromide SCHEMBL2478 0.67
N-Propyl Bromide SCHEMBL5756591 0.67
SCHEMBL1525977 0.65
N-Propyl Bromide SCHEMBL5810818 0.63
N-Propyl Bromide SCHEMBL1258651 0.63
N-Propyl Bromide SCHEMBL643826 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880539-B1 NUCLEOSIDE ANALOGUES AMERSHAM BIOSCIENCES UK LTD (GB) 2003-06-25 EP disclosed
US-6313286-B1 NUCLEOSIDE WITH DEGENERATE BASE AND REPORTER MOLECULE; FOR INCORPORATION INTO OLIGONUCLEOTIDES AS LABELS; HYBRIDIZATION; IMMUNOASSAY AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 2001-11-06 US disclosed
EP-0880539-A1 NUCLEOSIDE ANALOGUES Amersham Pharmacia Biotech UK Limited (GB) 1998-12-02 EP disclosed
WO-1997028177-A1 NUCLEOSIDE ANALOGUES AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 1997-08-07 WO disclosed